We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Panel Advises Phased Approach on Nanomaterial Risk Evaluations
EC Panel Advises Phased Approach on Nanomaterial Risk Evaluations
Manufacturers of medical devices that contain nanomaterials should use a phased approach to evaluate risk in order to avoid unnecessary testing, an expert committee of the European Commission recommends.